Spain Commits Over €120 Million to Advance Health Research and Innovation

The Ministry of Science, Innovation and Universities (MICIU) in Spain, through the Carlos III Health Institute (ISCIII), allocates more than 120 million euros to health research projects and personnel contracts.

The Minister of Science, Innovation and Universities, Diana Morant, emphasized that “the Spanish Government is committed to science, people’s health, and the professionals who make biomedical and healthcare advances possible.”

Specifically, the provisional resolution for the grant award for the PI call for R&D&I Projects in Health has been published, within the framework of the Strategic Action in Health (SAH) 2025, the main tool for funding biomedical and healthcare research in Spain. The provisional resolution for this call awards €81.6 million for 498 health research projects.

Fundable projects in Spain include research on cancer; endocrine, digestive, and surgical diseases; chronic, respiratory, inflammatory, and nephrological pathologies; pediatrics, perinatal medicine, and congenital and metabolic abnormalities; epidemiology, public health, health services, health technologies, and telemedicine; infectious diseases and AIDS; neurological and mental disorders; and cardiovascular diseases, which will improve prevention, diagnosis, treatment, and care.

Spain boosts biomedical progress with €120M funding for 498 research projects, 250 contracts, and health technology initiatives under AES 2025

This provisional resolution is added to another 10 resolutions published before the summer, which allocate 40 million euros to contracts for more than 250 people and other research projects in Spain.

Specifically, €18 million is allocated to the Sara Borrell, Juan Rodés, and Miguel Servet contracts, totaling 90 contracts, and more than €5 million for Mobility (M-BAE and M-AES), Research Intensification, Health R&D&I Management in IIS, and Bioinformatics Technical Personnel.

In addition, more than €16 million is allocated to other research projects in Spain, including the provisional resolutions of the Independent Clinical Research calls (almost €13 million for 14 projects), the Incorporation of New Groups into the CIBER Consortium, and Health Technological Development (€3.3 million for 18 projects).

The ISCIII’s AES 2025 will be completed in the coming months with the provisional award resolutions for the Río Hortega contract calls, the PFIS and i-PFIS predoctoral contracts, and the International Collaboration (AC) Projects.

__

(Featured image by Marek Studzinski  via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in GACETA MEDICA. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.